Sarcoidosis presenting as bilateral optic neuritis after ChAdOx1 nCoV-19 vaccination

Sarcoidosis presenting as bilateral optic neuritis after ChAdOx1 nCoV-19 vaccination

Sarcoidosis is an idiopathic granulomatous disease and can virtually affect any organ system. Multiple factors, including tubercular antigens organic and environmental exposures, have been implicated in its pathogenesis. In addition to drugs, sarcoid-like reactions have been reported following vari...

Full description

Bibliographic Details
Main Authors:	Amarendra Kumar Shukla, Amrutha Peter, Jitendra Kishore Bhargava, Veerendra Arya, Manish Kumar Gupta, Nishtha Yadav, Pawan Tiwari
Format:	Article
Language:	English
Published:	PAGEPress Publications 2022-06-01
Series:	Monaldi Archives for Chest Disease
Subjects:	sarcoidosis COVID19 vaccination ChadOx-1 n-CoV vaccine (COVISHIELD) optic neuritis
Online Access:	https://www.monaldi-archives.org/index.php/macd/article/view/2279

Similar Items

A rare case of bilateral optic neuritis post-Covishield (ChAdOx1-S [recombinant]) vaccination
by: Tanie Natung, et al.
Published: (2023-01-01)

Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SP
by: Sue Ann Costa Clemens, et al.
Published: (2022-10-01)

Covid Antibody Titers in Cancer Patients Following Vaccination with ChAdOx1 nCOV-19 Vaccine
by: Ashish Chavan, et al.

Bilateral Optic Neuritis after COVID-19 Vaccination: A Case Report
by: Ching-Chih Liu, et al.
Published: (2022-11-01)

Acute Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccine: A Case Report and Literature Review
by: Chia-Tung Wu, et al.
Published: (2022-04-01)

Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (Covishield<sup>TM</sup>) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021
by: Sharan Murali, et al.
Published: (2022-06-01)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
by: Jer-Hwa Chang, et al.
Published: (2022-02-01)

Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports
by: Mukesh Kumar Sah, et al.
Published: (2022-05-01)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
by: Jinnam Kim, et al.
Published: (2023-04-01)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
by: Tamara Garibashvili, et al.
Published: (2022-06-01)

Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project
by: Valéria Valim, et al.
Published: (2022-08-01)

Effectiveness of the chAdOx1 nCoV-19 vaccine in preventing COVID-19 infection
by: Tarana Sarwat, et al.
Published: (2022-01-01)

ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago
by: Chavin D. Gopaul, et al.
Published: (2022-03-01)

Fatal myositis, rhabdomyolysis and compartment syndrome after ChAdOx1 nCoV-19 vaccination
by: Szu-Ting Huang, et al.
Published: (2022-12-01)

Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination
by: Shane P. Comer, et al.
Published: (2022-02-01)

Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S
by: Bas de Laat, et al.
Published: (2022-07-01)

Incidence of early adverse events following covishield (ChAdOx1 nCoV-19) vaccination: A prospective study
by: Gajanan D Velhal, et al.
Published: (2022-01-01)

Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment
by: Passakorn Wanchaijiraboon, et al.
Published: (2022-10-01)

Immunogenicity of ChAdOx1 nCoV-19 Booster Vaccination Following Two CoronaVac Shots in Healthcare Workers
by: Wisit Prasithsirikul, et al.
Published: (2022-01-01)

Adverse Events Following Immunization Associated with the First and Second Doses of the ChAdOx1 nCoV-19 Vaccine among Healthcare Workers in Korea
by: Minji Jeon, et al.
Published: (2021-09-01)

Evaluation of Antibody Response to Heterologous Prime–Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study
by: Davide Firinu, et al.
Published: (2021-12-01)

Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
by: Jie Wei, et al.
Published: (2023-02-01)

Case report: Early onset Marin-Amat syndrome after receiving ChAdOx1 nCoV-19 vaccination
by: Ping-Feng Tsai, et al.
Published: (2022-11-01)

Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues
by: Anita Badbaran, et al.
Published: (2021-12-01)

Impact of Improper Storage of ChAdOx1-S (AstraZeneca) Vaccine on Its Efficacy and Safety
by: Marek Mikołajczyk, et al.
Published: (2022-12-01)

Acute Polyserositis with Cardiac Tamponade and Bilateral Refractory Pleural Effusion after ChAdOx1 nCoV-19 Vaccination
by: Guan-Yi Li, et al.
Published: (2022-08-01)

Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination
by: Jimin Hwang, et al.
Published: (2022-03-01)

Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study
by: Nattaya Teeyapun, et al.
Published: (2022-10-01)

Immunological Response to ChAdOx1 nCoV-19 Vaccine among Health Care Workers at a Tertiary Care Hospital in Chennai
by: P. Sneka, et al.
Published: (2022-03-01)

Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia
by: Salma Al Bahrani, et al.
Published: (2021-09-01)

Possible side effects of ChAdOx1 nCov-19 vaccine in patients with sickle cell disease
by: Salam Alkindi, et al.
Published: (2021-09-01)

A Quantitative Benefit–Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy
by: Raffaele Palladino, et al.
Published: (2021-06-01)

ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis
by: Wisit Prasithsirikul, et al.
Published: (2022-06-01)

Serious events following COVID‐19 vaccination with ChAdOx1 nCoV‐19 vaccine (Vaxzevria): A short case series from Iran
by: Nasim Khajavirad, et al.
Published: (2022-02-01)

Severe but Self-Limiting Polyarthralgia with Functional Impairment Following ChAdOx1 nCov-19 Vaccination in an Elderly Recipient
by: Joel Ern Zher Chan, et al.
Published: (2021-10-01)

Intradermal ChAdOx1 Vaccine Following Two CoronaVac Shots: A Case Report
by: Ekachai Singhatiraj, et al.
Published: (2021-09-01)

A case of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) with thrombosis of the superior mesenteric artery after ChAdOx1 nCov-19 COVID-19 Vaccine
by: Laura Pini, et al.
Published: (2021-12-01)

Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India
by: Anil Bhandari, et al.
Published: (2022-01-01)

Palatal petechiae: an uncommon oral adverse effect of COVID-19 vaccine
by: Bhawna Sayare, et al.
Published: (2021-09-01)

Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2
by: Marlene Plüß, et al.
Published: (2022-01-01)